SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-23-015300
Filing Date
2023-12-08
Accepted
2023-12-08 17:29:08
Documents
7
Period of Report
2023-12-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A drma_def14a.htm DEF 14A 193462
2 drma_def14aimg10.jpg GRAPHIC 999
3 drma_def14aimg11.jpg GRAPHIC 1295
4 drma_def14aimg2.jpg GRAPHIC 4924
5 drma_def14aimg7.jpg GRAPHIC 4842
6 drma_def14aimg8.jpg GRAPHIC 1257
7 drma_def14aimg9.jpg GRAPHIC 1066
  Complete submission text file 0001654954-23-015300.txt   215066
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40739 | Film No.: 231476437
SIC: 2834 Pharmaceutical Preparations